AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1642114
Drug: Oxcarbazepine (OXC)
RxNorm normalized name: Oxcarbazepine
DrugBank: Oxcarbazepine (DB00776)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (OXC) 600 mg
Trial: 6299159
Drug: Steroid/antibiotic combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid/antibiotic combination product (dexamethasone, neomycin, and polymyxin B) for three days prior to surgery and three weeks following surgery
Trial: 6299159
Drug: Steroid/antibiotic combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid/antibiotic combination product
Trial: 11573667
Drug: Ropivacaine 5
RxNorm normalized name: fentanyl-ropivacaine 5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 5 mg ml(-1) in glucose 50 mg ml(-1)
Trial: 11573667
Drug: Ropivacaine 5
RxNorm normalized name: fentanyl-ropivacaine 5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 5 mg ml(-1) in glucose 10 mg ml(-1)
Trial: 8955861
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation of selegiline HCl (4 x 5 mg tablets)
Trial: 7013971
Drug: Radiotherapy-chemotherapy (RT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy-chemotherapy (RT & CT)
Trial: 28222742
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g HAM-RS2 muffins (n = 11)
Trial: 28222742
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g HAM-RS2 muffins (control; n = 7)
Trial: 16032784
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (120 mg vitamin C, 30 mg vitamin E, 6 mg beta‐carotene, 100 microg selenium, and 20 mg zinc)
Trial: 12170041
Drug: Epidural top-up
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural top-up with 10 ml ropivacaine, 0.75% (group 1, n = 10)
Trial: 25525981
Drug: LG3, LTBP2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LG3, LTBP2, Cathepsin L
Trial: 20420579
Drug: Low-fat/high-complex carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat/high-complex carbohydrate diet supplemented with 1.24 g/day of long-chain n-3 polyunsaturated fatty acid (LFHCC n-3)
Trial: 20420579
Drug: Low-fat/high-complex carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat/high-complex carbohydrate diet with 1 g/day of sunflower oil high in oleic acid (LFHCC)
Trial: 18686769
Drug: Scaling/root planing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling/root planing plus test gel application (triclosan 1% + polydimethylsiloxane 13%)
Trial: 18686769
Drug: Scaling/root planing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling/root planing plus control gel application (polydimethylsiloxane 13%)
Trial: 15625365
Drug: Standard-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (SD) ifosfamide (1.5 g/m2/d, days 1 through 4) plus doxorubicin (60 mg/m2)
Trial: 15625365
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) ifosfamide (3.0 g/m2, days 1 through 4) plus doxorubicin (60 mg/m2)
Trial: 10325738
Drug: Picolax (sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picolax (sodium picosulphate 10 mg/sachet with magnesium citrate) and clear fluids
Trial: 10325738
Drug: Bisacodyl tablets
RxNorm normalized name: Bisacodyl;Polyethylene Glycol 3350/Potassium Chloride/Sodium Bicarbonate/Sodium Chloride 5 MG; 210 GM-0.74 GM-2.86 GM-5.6 GM Oral Kit [HALFLYTELY & BISACODYL TABLETS BOWEL PREP]
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bisacodyl tablets with an unrestricted diet and a phosphate enema
Trial: 8946103
Drug: Control toothpaste
RxNorm normalized name: Sodium Fluoride Dental Paste [TARTAR CONTROL TOOTHPASTE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control toothpaste containing no caries‐preventive agent
Trial: 6703927
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (100 mg ASA + 75 mg DPM, t.d.s.)
Trial: 6703927
Drug: High-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose aspirin (300 mg ASA + 75 mg DPM, t.d.s.)
Trial: 29719379
Drug: Orodispersible film
RxNorm normalized name: Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orodispersible film (ODF) of tadalafil (20 mg)
Trial: 29719379
Drug: Film-coated tablet
RxNorm normalized name: ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Film-coated tablet (FCT) of tadalafil (20 mg)
Trial: 22353022
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg weekly for 96 weeks
Trial: 16282540
Drug: Basic rehabilitation
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic rehabilitation program with additional arm, leg, or air splint therapy
Trial: 9481631
Drug: Zinc-fortified bread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc-fortified bread providing 2 mg/kg/day elemental zinc acetate for 90 days
Trial: 7874898
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg four times daily added to standard enteral nutrition feeding protocol
Trial: 2404046
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg once a day)
Trial: 2404046
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg three times a day)
Trial: 2404046
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus dipyridamole (325 mg and 75 mg together three times a day)
Trial: 2404046
Drug: Sulfinpyrazone (267
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfinpyrazone (267 mg three times a day)
Trial: 369471
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of DTgammaE zinc phosphate daily intramuscularly for about seven days (study 1)
Trial: 369471
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of nonlasting DTgammaE in saline daily intramuscularly for eight days (study 2)
Trial: 369471
Drug: Neuroleptic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic therapy maintained in six patients and drug-free in two patients (study 2)
Trial: 15207200
Drug: Pharmaceutical intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical intervention in a monitoring programme for type-2 diabetics
Trial: 9102059
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU intranasal calcitonin daily
Trial: 9102059
Drug: 20 intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 intramuscular injections of 50 mg nandrolone decanoate plus placebo nasal spray
Trial: 9102059
Drug: 20 injections
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 injections of 50 mg nandrolone decanoate plus 400 IU intranasal calcitonin daily
Trial: 9102059
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate and intranasal calcitonin
Trial: 22289649
Drug: Menaquinone-7 (MK-7)
RxNorm normalized name: menaquinone 7
DrugBank: Menaquinone 7 (DB13075)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menaquinone-7 (MK-7) supplementation at doses around RDA (10, 20, 45, 90, 180, or 360 μg)
Trial: 8644836
Drug: Pet therapy
RxNorm normalized name: Pet Pectillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pet therapy intervention for 1 hr a day for 5 consecutive days
Trial: 1996747
Drug: Propofol/Ketamine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/Ketamine combination
Trial: 1996747
Drug: Propofol/Fentanyl combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/Fentanyl combination
Trial: 24279638
Drug: Interdisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interdisciplinary treatment (12 sessions for 6 weeks)
Trial: 24279638
Drug: Standard-of-care pharmacologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care pharmacologic treatment
Trial: 18795255
Drug: AVAPS therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVAPS therapy
Trial: 18795255
Drug: NIV-PS therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIV-PS therapy
Trial: 15088288
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg daily by injection
Trial: 9554521
Drug: Epirubicin, etoposide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin, etoposide, cisplatin, and lonidamine (EEP‐L)
Trial: 9554521
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (5‐FU/6S‐LV and EEP‐L)
Trial: 9554521
Drug: EEP‐L
RxNorm normalized name: Ethinyl Estradiol and Levonorgestrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EEP‐L
Trial: 3046542
Drug: Transdermal clonidine
RxNorm normalized name: clonidine Transdermal System
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal clonidine hydrochloride (Catapres‐TTS No. 2) treatment for one week
Trial: 25403343
Drug: Oral topiramate
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral topiramate (TPM)
Trial: 25403343
Drug: Intravenous topiramate
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous topiramate (TPM)
Trial: 25403343
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) 100 mg dose
Trial: 15249451
Drug: Low‐radiation‐dose spiral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐radiation‐dose spiral CT (LDCT) scan
Trial: 12034159
Drug: CRP levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRP levels >0.9 mg/dl
Trial: 2524166
Drug: 10 ng.kg‐1.min‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ng.kg‐1.min‐1 ANF infusion
Trial: 2524166
Drug: 25 ng.kg‐1.min‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 ng.kg‐1.min‐1 ANF infusion
Trial: 1119691
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy without endocrine ablation
Trial: 19333080
Drug: Purified chick
RxNorm normalized name: rabies vaccine, purified chick embryo cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified chick embryo cell rabies vaccine administered intramuscularly or intradermally
Trial: 16394700
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia followed by patient-controlled analgesia with intravenous morphine
Trial: 15235161
Drug: Indomethacin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.1 mg/kg/dose intravenously, 3 doses)
Trial: 11726250
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate loading (20 g per day for 7 days)
Trial: 2855221
Drug: Propranolol-adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol-adrenaline infusion
Trial: 2855221
Drug: Supramaximal dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supramaximal dose of GRF 1-44 (200 micrograms, i.v.)
Trial: 24177278
Drug: Innovative dental
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Innovative dental implant design with tapered and cylindrical shape, placed under different protocols.
Trial: 21164352
Drug: Olanzapine (16.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (16.2 mg for AA, 16.6 mg for CA)
Trial: 17361520
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (basic treatment including liver protecting medicines, diuretics, and supportive drugs)
Trial: 30442030
Drug: Prolonged slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged slow expiration respiratory physiotherapy treatment
Trial: 30066937
Drug: Aloe polysaccharide
RxNorm normalized name: Aloe Polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe polysaccharide (APS) at doses of 20, 40, and 80 µg/ml
Trial: 27217345
Drug: Low-dose ASCs
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ASCs (2 × 10(6) cells)
Trial: 27217345
Drug: Medium-dose ASCs
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose ASCs (10 × 10(6) cells)
Trial: 27217345
Drug: High-dose ASCs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ASCs (50 × 10(6) cells)
Trial: 27217345
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of ASCs
Trial: 23008325
Drug: Fluorouracil (FU)
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil (FU) monotherapy
Trial: 20362850
Drug: Low fluidic
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fluidic parameters (aspiration flow rate 25 cc/min; bottle height 70 cm and 90 cm; vacuum ≤400 mm Hg)
Trial: 20362850
Drug: High fluidic
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fluidic parameters (aspiration flow rate 40 cc/min; bottle height 90 cm and 110 cm; vacuum ≤650 mm Hg)
Trial: 18613861
Drug: Modafinil 100
RxNorm normalized name: modafinil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 100 mg, 200 mg, and 400 mg single doses (study 1)
Trial: 18613861
Drug: Modafinil 100
RxNorm normalized name: modafinil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 100 mg twice daily for 7 days (study 2)
Trial: 15970290
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (3.9 mg/week for 6 months)
Trial: 11854872
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia during surgery and intravenous opiate analgesia after surgery
Trial: 11703279
Drug: Oral liarozole
RxNorm normalized name: letrozole Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral liarozole 75 mg twice daily for 12 weeks
Trial: 8314680
Drug: H.E.L.P. application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H.E.L.P. application (Group A)
Trial: 8314680
Drug: H.E.L.P. application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H.E.L.P. application (Group B)
Trial: 3725001
Drug: Amitriptyline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (200 mg)
Trial: 3725001
Drug: Trazodone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone (400 mg)
Trial: 31996411
Drug: Amiloride/hydrochlorothiazide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride/hydrochlorothiazide (5 mg/50 mg daily)
Trial: 27180444
Drug: Olmesartan medoxomil/hydrochlorothiazide
RxNorm normalized name: olmesartan medoxomil/hydrochlorothiazide 40 mg-25 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg
Trial: 27180444
Drug: Olmetec Plus
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmetec Plus 20/12.5 mg
Trial: 25910081
Drug: Home food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home food environment characteristics (e.g., healthy shopping, selecting healthy beverages, healthy food preparation, serving behaviors)
Trial: 16647914
Drug: Gynecological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynecological treatment plus somatocognitive therapy
Trial: 16647914
Drug: Standard gynecological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard gynecological treatment
Trial: 1624241
Drug: Nitrofurantoin 50
RxNorm normalized name: nitrofurantoin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin 50 mg
Trial: 1624241
Drug: Trimethoprim 50
RxNorm normalized name: trimethoprim 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim 50 mg
Trial: 6143965
Drug: Anti-LPS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-LPS treatment (freeze-dried human plasma rich in anti-LPS immunoglobulin G)
Trial: 6143965
Drug: Anti-LPS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-LPS treatment
Trial: 30898550
Drug: Deferoxamine mesylate
RxNorm normalized name: Deferoxamine Mesylate
DrugBank: Deferoxamine (DB00746)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Deferoxamine mesylate (32 mg/kg per day) for 3 consecutive days
Trial: 30898550
Drug: Placebo (saline)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline) infusions for 3 consecutive days
Trial: 26899537
Drug: Short-term statin
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term statin treatment
Trial: 26899537
Drug: High-dose statins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose statins
Trial: 23214255
Drug: Bromocriptine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine + Compound Xuanju Capsule (CXC)
Trial: 11094650
Drug: Continuous hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous hormone replacement therapy (HRT)
Trial: 8438612
Drug: Parenteral administration
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral administration of a killed typhoid vaccine
Trial: 8438612
Drug: Parenteral vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral vaccination
Trial: 3514550
Drug: person‐centered insight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: person‐centered insight therapy
Trial: 25941016
Drug: AVP-825 (22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVP-825 (22 mg sumatriptan powder)
Trial: 17893569
Drug: Low proportions
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low proportions of CD3+CD4+CD69+ cells before treatment
Trial: 17893569
Drug: Low proportions
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low proportions of CD3+CD56+ cells before treatment
Trial: 11952312
Drug: Sequential CT-guided
RxNorm normalized name: brompheniramine tannate Chewable Tablet [BroveX CT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential CT-guided puncture (group B)
Trial: 9607383
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg irbesartan
Trial: 1700218
Drug: Low-dose 443C81
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose 443C81 (0.46 +/- 0.11 microgram/ml)
Trial: 1700218
Drug: High-dose 443C81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose 443C81 (1.0 +/- 0.2 microgram/ml)
Trial: 1700218
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses of 443C81
Trial: 21654265
Drug: Allopurinol 200
RxNorm normalized name: allopurinol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 200 mg/d
Trial: 14574579
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (4 x (5 g Cr monohydrate + 2.5 g maltodextrin)/day)
Trial: 14574579
Drug: Placebo supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplementation (4 x 7.5 g maltodextrin/day)
Trial: 8159193
Drug: Six-week taper
RxNorm normalized name: caper berry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six-week taper period
Trial: 8159193
Drug: Nine-month taper
RxNorm normalized name: caper berry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nine-month taper period
Trial: 8159193
Drug: Spikes in
RxNorm normalized name: spike lavender oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spikes in the electroencephalogram at tapering
Trial: 31486660
Drug: Control (reflecting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (reflecting on daily activities)
Trial: 21306457
Drug: Relaxation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation therapy (20 minutes daily from the day before surgery to the third postoperative day)